Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
Gerald W. Prager(Comprehensive Cancer Center Vienna), Christoph Zielinski(Vienna General Hospital), Markus Raderer(Medical University of Vienna), Alexander Reinthaller(Medical University of Vienna), Matthias Unseld(Medical University of Vienna), Mir Alireza Hoda(Comprehensive Cancer Center Vienna), Lukas Baumann(Statistics Austria), Philipp B. Staber(Vienna General Hospital), Ulrich Jäger(Medical University of Vienna), Daniela Bianconi(Comprehensive Cancer Center Vienna), Walter Berger(Comprehensive Cancer Center Vienna), Maria Sibilia(Comprehensive Cancer Center Vienna), Fredrik Waneck(Comprehensive Cancer Center Vienna), Christoph Grimm(Comprehensive Cancer Center Vienna), Markus Kieler(Comprehensive Cancer Center Vienna), H. Kölbl(Comprehensive Cancer Center Vienna), Robert M. Mader(Centre de Recherche en Économie et Management), Leonhard Müllauer(Hochschule Campus Wien), Fritz Wrba(University of Vienna), Thorsten Fuereder(Medical University of Vienna)
Cited by 14
Related Papers
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer
|Radiotherapy and Oncology|2011|739
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer
|Radiotherapy and Oncology|2007|541
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532